Table 3 Enrichment of KEGG pathways in the NR1H4 high expression group
From: Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma
No | GS DETAILS | SIZE | ES | NES | NOM p-val | FDR q-val | |
|---|---|---|---|---|---|---|---|
1 | KEGG_N_GLYCAN_BIOSYNTHESIS | 42 | 0.602 | 2.223 | 0.000 | 0.000 | |
2 | KEGG_PROTEASOME | 38 | 0.578 | 1.949 | 0.000 | 0.000 | |
3 | KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT | 33 | 0.574 | 1.702 | 0.250 | 0.013 | |
4 | KEGG_CELL_CYCLE | 100 | 0.537 | 1.763 | 0.000 | 0.016 | |
5 | KEGG_MISMATCH_REPAIR | 19 | 0.625 | 1.848 | 0.000 | 0.020 | |
6 | KEGG_DNA_REPLICATION | 32 | 0.640 | 1.876 | 0.000 | 0.027 | |
7 | KEGG_P53_SIGNALING_PATHWAY | 59 | 0.622 | 1.581 | 0.000 | 0.095 | |
8 | KEGG_NUCLEOTIDE_EXCISION_REPAIR | 37 | 0.569 | 1.582 | 0.000 | 0.107 | |
9 | KEGG_PROTEIN_EXPORT | 19 | 0.614 | 1.552 | 0.000 | 0.116 | |
10 | KEGG_RENAL_CELL_CARCINOMA | 59 | 0.513 | 1.584 | 0.000 | 0.122 | |
11 | KEGG_HOMOLOGOUS_RECOMBINATION | 20 | 0.402 | 1.554 | 0.000 | 0.128 | |
12 | KEGG_BASAL_TRANSCRIPTION_FACTORS | 26 | 0.539 | 1.509 | 0.000 | 0.141 | |
13 | KEGG_TYPE_II_DIABETES_MELLITUS | 43 | 0.334 | 1.487 | 0.000 | 0.141 | |
14 | KEGG_CHRONIC_MYELOID_LEUKEMIA | 62 | 0.463 | 1.485 | 0.000 | 0.143 | |
15 | KEGG_BLADDER_CANCER | 37 | 0.573 | 1.492 | 0.000 | 0.150 | |
16 | KEGG_MTOR_SIGNALING_PATHWAY | 46 | 0.424 | 1.488 | 0.000 | 0.150 | |
17 | KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS | 17 | 0.634 | 1.522 | 0.000 | 0.152 | |
18 | KEGG_PANCREATIC_CANCER | 64 | 0.509 | 1.523 | 0.000 | 0.164 | |
19 | KEGG_APOPTOSIS | 81 | 0.470 | 1.451 | 0.200 | 0.230 | |
20 | KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY | 58 | 0.374 | 1.433 | 0.000 | 0.268 | |